Abstract
Electronegative low-density lipoprotein (LDL(−)) is a minor modified fraction of human plasma LDL with several atherogenic properties. Among them is increased bioactive lipid mediator content, such as lysophosphatidylcholine (LPC), non-esterified fatty acids (NEFA), ceramide (Cer), and sphingosine (Sph), which are related to the presence of some phospholipolytic activities, including platelet-activating factor acetylhydrolase (PAF-AH), phospholipase C (PLC), and sphingomyelinase (SMase), in LDL(−). However, these enzymes’ activities do not explain the increased Sph content, which typically derives from Cer degradation. In the present study, we analyzed the putative presence of ceramidase (CDase) activity, which could explain the increased Sph content. Thin layer chromatography (TLC) and lipidomic analysis showed that Cer, Sph, and NEFA spontaneously increased in LDL(−) incubated alone at 37 °C, in contrast with native LDL(+). An inhibitor of neutral CDase prevented the formation of Sph and, in turn, increased Cer content in LDL(−). In addition, LDL(−) efficiently degraded fluorescently labeled Cer (NBD-Cer) to form Sph and NEFA. These observations defend the existence of the CDase-like activity’s association with LDL(−). However, neither the proteomic analysis nor the Western blot detected the presence of an enzyme with known CDase activity. Further studies are thus warranted to define the origin of the CDase-like activity detected in LDL(−).
Funder
Instituto de Salud Carlos III, Spanish Ministry of Health
CIBER
Ministerio de Ciencia e Innovación
CIBERDEM
CIBERCV
Quality Research Group
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference48 articles.
1. Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis;Tabas;Circulation,2007
2. Electronegative LDL: A useful biomarker of cardiovascular risk?;Estruch;Clin. Lipidol.,2012
3. Electronegative low-density lipoprotein;Curr. Opin. Lipidol.,2004
4. Ke, L.-Y., Law, S.H., Mishra, V.K., Parveen, F., Chan, H.-C., Lu, Y.-H., and Chu, C.-S. (2020). Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases. Biomedicines, 8.
5. Pro-inflammatory action of LDL(−) on mononuclear cells is counteracted by increased IL10 production;Bancells;Biochim. Biophys. Acta,2007
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献